[Clinical features and prognosis of pneumocystis pneumonia in patients treated with rituximab for autoimmune diseases].
摘要
In patients treated with rituximab for autoimmune diseases, the number of B lymphocytes in peripheral blood and the plasma level of immunoglobulins but not CD3(+), CD4(+), and CD8(+)T lymphocyte counts may play an important role in the pathogenesis of PCP. These patients are not vulnerable to be complicated with CMV pneumonia.
引用本文（GB/T 7714）
W Zhang, X Wang, Yixin Hu, 等. [Clinical features and prognosis of pneumocystis pneumonia in patients treated with rituximab for autoimmune diseases].[J]. PubMed, 2020.
引文网络
本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。